STAAR Historical Financial Ratios

STAA Stock

USD 17.46 0.31 1.74%

STAAR Surgical is promptly reporting on over 112 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 5.75, Free Cash Flow Yield of 0.0074, Invested Capital of 0.0 or Operating Cash Flow Per Share of 0.98 will help investors to properly organize and evaluate STAAR Surgical financial condition quickly.

Quick Ratio Current Ratio

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STAAR Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.

About STAAR Financial Ratios Analysis

STAAR SurgicalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate STAAR Surgical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on STAAR financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across STAAR Surgical history.

STAAR Surgical Financial Ratios Chart

At present, STAAR Surgical's Price To Sales Ratio is projected to increase based on the last few years of reporting. The current year's PTB Ratio is expected to grow to 26.04, whereas Days Sales Outstanding is forecasted to decline to 51.86.

Price To Sales Ratio Ptb Ratio Days Sales Outstanding Book Value Per Share

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing STAAR Surgical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on STAAR Surgical sales, a figure that is much harder to manipulate than other STAAR Surgical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Most ratios from STAAR Surgical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into STAAR Surgical current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STAAR Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.At present, STAAR Surgical's Price To Sales Ratio is projected to increase based on the last few years of reporting. The current year's PTB Ratio is expected to grow to 26.04, whereas Days Sales Outstanding is forecasted to decline to 51.86.

	2016	2021	2022	2025 (projected)
Days Sales Outstanding	78.67	68.94	92.16	51.86
PTB Ratio	18.32	16.67	2.99	26.04

Days Sales Outstanding Ptb Ratio

STAAR Surgical fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow
Price To Sales Ratio		0.93	-0.28	0.34	0.56	0.73	0.36	-0.36	0.93	1.0	0.79	0.73	0.88	0.64	-0.7	0.81	0.43	0.62	0.84	0.81	0.33	0.94	-0.85	0.92	0.7	0.84
Ptb Ratio	0.93		-0.58	0.2	0.45	0.71	0.41	-0.48	1.0	0.93	0.83	0.66	0.9	0.67	-0.73	0.62	0.27	0.51	0.66	0.61	0.12	0.85	-0.64	0.83	0.6	0.66
Days Sales Outstanding	-0.28	-0.58		0.3	-0.16	-0.39	-0.28	0.69	-0.58	-0.29	-0.61	-0.33	-0.45	-0.52	0.24	0.19	0.31	0.1	0.12	0.15	0.47	-0.26	-0.21	-0.23	-0.14	0.11
Book Value Per Share	0.34	0.2	0.3		0.51	0.68	0.17	0.67	0.2	0.34	0.37	0.57	0.44	0.57	-0.3	0.18	0.99	0.92	0.72	0.62	0.96	0.15	-0.31	0.07	0.78	0.72
Free Cash Flow Yield	0.56	0.45	-0.16	0.51		0.75	-0.18	-0.16	0.45	0.56	0.74	0.94	0.38	0.76	0.08	0.35	0.46	0.46	0.73	0.72	0.57	0.63	-0.29	0.56	0.89	0.74
Operating Cash Flow Per Share	0.73	0.71	-0.39	0.68	0.75		0.38	-0.05	0.71	0.73	0.93	0.92	0.83	0.98	-0.49	0.27	0.69	0.8	0.75	0.67	0.57	0.58	-0.39	0.49	0.94	0.75
Average Payables	0.36	0.41	-0.28	0.17	-0.18	0.38		-0.02	0.41	0.35	0.36	0.1	0.64	0.35	-0.74	0.06	0.26	0.41	0.12	0.0	-0.02	0.12	-0.29	0.09	0.15	0.12
Capex To Depreciation	-0.36	-0.48	0.69	0.67	-0.16	-0.05	-0.02		-0.48	-0.37	-0.42	-0.2	-0.21	-0.16	0.04	-0.23	0.64	0.45	0.1	0.02	0.66	-0.53	0.12	-0.56	0.07	0.09
Pb Ratio	0.93	1.0	-0.58	0.2	0.45	0.71	0.41	-0.48		0.93	0.83	0.66	0.9	0.67	-0.73	0.62	0.27	0.51	0.66	0.61	0.12	0.85	-0.64	0.83	0.6	0.66
Ev To Sales	1.0	0.93	-0.29	0.34	0.56	0.73	0.35	-0.37	0.93		0.79	0.73	0.88	0.64	-0.7	0.81	0.42	0.62	0.84	0.81	0.32	0.94	-0.84	0.92	0.7	0.84
Free Cash Flow Per Share	0.79	0.83	-0.61	0.37	0.74	0.93	0.36	-0.42	0.83	0.79		0.91	0.83	0.95	-0.46	0.33	0.39	0.56	0.64	0.6	0.27	0.72	-0.39	0.64	0.83	0.65
Roic	0.73	0.66	-0.33	0.57	0.94	0.92	0.1	-0.2	0.66	0.73	0.91		0.65	0.92	-0.23	0.39	0.56	0.63	0.8	0.76	0.56	0.71	-0.4	0.63	0.96	0.8
Inventory Turnover	0.88	0.9	-0.45	0.44	0.38	0.83	0.64	-0.21	0.9	0.88	0.83	0.65		0.77	-0.88	0.49	0.52	0.74	0.68	0.6	0.29	0.68	-0.64	0.63	0.67	0.68
Net Income Per Share	0.64	0.67	-0.52	0.57	0.76	0.98	0.35	-0.16	0.67	0.64	0.95	0.92	0.77		-0.39	0.14	0.56	0.67	0.62	0.55	0.44	0.52	-0.24	0.42	0.89	0.63
Days Of Inventory On Hand	-0.7	-0.73	0.24	-0.3	0.08	-0.49	-0.74	0.04	-0.73	-0.7	-0.46	-0.23	-0.88	-0.39		-0.48	-0.42	-0.63	-0.46	-0.39	-0.14	-0.46	0.66	-0.45	-0.31	-0.46
Payables Turnover	0.81	0.62	0.19	0.18	0.35	0.27	0.06	-0.23	0.62	0.81	0.33	0.39	0.49	0.14	-0.48		0.27	0.39	0.76	0.79	0.31	0.86	-0.95	0.89	0.39	0.76
Capex To Revenue	0.43	0.27	0.31	0.99	0.46	0.69	0.26	0.64	0.27	0.42	0.39	0.56	0.52	0.56	-0.42	0.27		0.96	0.76	0.66	0.94	0.21	-0.42	0.14	0.77	0.75
Cash Per Share	0.62	0.51	0.1	0.92	0.46	0.8	0.41	0.45	0.51	0.62	0.56	0.63	0.74	0.67	-0.63	0.39	0.96		0.82	0.72	0.84	0.39	-0.55	0.31	0.81	0.82
Pocfratio	0.84	0.66	0.12	0.72	0.73	0.75	0.12	0.1	0.66	0.84	0.64	0.8	0.68	0.62	-0.46	0.76	0.76	0.82		0.96	0.77	0.78	-0.78	0.73	0.87	1.0
Interest Coverage	0.81	0.61	0.15	0.62	0.72	0.67	0.0	0.02	0.61	0.81	0.6	0.76	0.6	0.55	-0.39	0.79	0.66	0.72	0.96		0.7	0.79	-0.79	0.76	0.81	0.96
Capex To Operating Cash Flow	0.33	0.12	0.47	0.96	0.57	0.57	-0.02	0.66	0.12	0.32	0.27	0.56	0.29	0.44	-0.14	0.31	0.94	0.84	0.77	0.7		0.21	-0.38	0.15	0.75	0.77
Pfcf Ratio	0.94	0.85	-0.26	0.15	0.63	0.58	0.12	-0.53	0.85	0.94	0.72	0.71	0.68	0.52	-0.46	0.86	0.21	0.39	0.78	0.79	0.21		-0.8	0.99	0.61	0.78
Days Payables Outstanding	-0.85	-0.64	-0.21	-0.31	-0.29	-0.39	-0.29	0.12	-0.64	-0.84	-0.39	-0.4	-0.64	-0.24	0.66	-0.95	-0.42	-0.55	-0.78	-0.79	-0.38	-0.8		-0.82	-0.45	-0.78
Income Quality	0.92	0.83	-0.23	0.07	0.56	0.49	0.09	-0.56	0.83	0.92	0.64	0.63	0.63	0.42	-0.45	0.89	0.14	0.31	0.73	0.76	0.15	0.99	-0.82		0.53	0.74
Roe	0.7	0.6	-0.14	0.78	0.89	0.94	0.15	0.07	0.6	0.7	0.83	0.96	0.67	0.89	-0.31	0.39	0.77	0.81	0.87	0.81	0.75	0.61	-0.45	0.53		0.87
Ev To Operating Cash Flow	0.84	0.66	0.11	0.72	0.74	0.75	0.12	0.09	0.66	0.84	0.65	0.8	0.68	0.63	-0.46	0.76	0.75	0.82	1.0	0.96	0.77	0.78	-0.78	0.74	0.87

Click cells to compare fundamentals

STAAR Surgical Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether STAAR Surgical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STAAR Surgical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Staar Surgical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Staar Surgical Stock:

How To Invest In STAAR

Details

Is STAAR Stock a good investment?

Details

What is STAAR Surgical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STAAR Surgical. If investors know STAAR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STAAR Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.018

Earnings Share

(0.41)

Revenue Per Share

6.39

Quarterly Revenue Growth

(0.36)

Return On Assets

(0.02)

The market value of STAAR Surgical is measured differently than its book value, which is the value of STAAR that is recorded on the company's balance sheet. Investors also form their own opinion of STAAR Surgical's value that differs from its market value or its book value, called intrinsic value, which is STAAR Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STAAR Surgical's market value can be influenced by many factors that don't directly affect STAAR Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between STAAR Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if STAAR Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STAAR Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Shareholders Equity Per Share	Debt To Equity
Capex Per Share	Graham Net Net
Average Receivables	Revenue Per Share
Interest Debt Per Share	Debt To Assets
Enterprise Value Over E B I T D A	Graham Number
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

STAAR Historical Financial Ratios

About STAAR Financial Ratios Analysis

STAAR Surgical Financial Ratios Chart

Price To Sales Ratio

Ptb Ratio

Book Value Per Share

STAAR Surgical fundamentals Correlations

STAAR Surgical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Ev To Operating Cash Flow	+ 1.0	Pocfratio
Capex To Revenue	+ 0.99	Book Value Per Share
Income Quality	+ 0.99	Pfcf Ratio
Net Income Per Share	+ 0.98	Operating Cash Flow Per Share

Days Payables Outstanding	- 0.95	Payables Turnover
Days Of Inventory On Hand	- 0.88	Inventory Turnover
Days Payables Outstanding	- 0.85	Price To Sales Ratio
Days Payables Outstanding	- 0.84	Ev To Sales
Income Quality	- 0.82	Days Payables Outstanding
Days Payables Outstanding	- 0.8	Pfcf Ratio